⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28669244 | 0.72 | — | — | |
| SCHEMBL27285732 | 0.72 | — | — | |
| SCHEMBL3851657 | 0.71 | — | — | |
| SCHEMBL23229950 | 0.63 | — | — | |
| SCHEMBL15690190 | 0.58 | — | — | |
| SCHEMBL15690191 | 0.58 | — | — | |
| SCHEMBL28261693 | 0.54 | — | — | |
| SCHEMBL20245049 | 0.53 | — | — | |
| SCHEMBL8922295 | 0.53 | — | — | |
| SCHEMBL27805069 | 0.51 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12594281-B2 | Pharmaceutical dosage forms and methods of use | EMALEX BIOSCIENCES, INC. (US) | 2026-04-07 | — | — | US | disclosed |
| US-20250288594-A1 | PHARMACEUTICAL DOSAGE FORMS AND METHODS OF USE | EMALEX BIOSCIENCES, INC. | 2025-09-18 | — | — | US | disclosed |